Novartis AG
NEW MYOKINES AND USES THEREOF
Last updated:
Abstract:
The present invention provides C1orf54 polypeptides and variants thereof with myokine activity as well as compositions and methods for treating, ameliorating or preventing muscle-related disorders.
Status:
Application
Type:
Utility
Filling date:
31 Jul 2019
Issue date:
12 May 2022